TOP:NASDAQTOP Financial Group Limited Analysis
Data as of 2026-05-05 - not real-time
$0.80
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: TOP trades at $0.80, comfortably below its 20‑day (0.81), 50‑day (0.87) and 200‑day (1.08) SMAs, confirming a bearish trend. The RSI sits at 45.9, indicating neutral momentum, while the MACD line is still negative despite a bullish‑signal histogram. Volume is on a decreasing trajectory and 30‑day volatility is extreme at 135%, suggesting heightened price swings.
Fundamental outlook: The company posted a 55.7% revenue surge, yet profit margins are deeply negative (‑122% net margin, ‑14% ROE) and EPS is –$0.14. Cash balances (~$15.6 M) dwarf modest debt (~$0.22 M), and the DCF‑derived fair value of $1.09 is well above the current price, implying potential undervaluation. However, the max drawdown of ‑66% and a “Extreme Greed” market sentiment flag add caution. The recent press release touts fast‑growing brokerage operations, but no concrete earnings improvements are evident.
Fundamental outlook: The company posted a 55.7% revenue surge, yet profit margins are deeply negative (‑122% net margin, ‑14% ROE) and EPS is –$0.14. Cash balances (~$15.6 M) dwarf modest debt (~$0.22 M), and the DCF‑derived fair value of $1.09 is well above the current price, implying potential undervaluation. However, the max drawdown of ‑66% and a “Extreme Greed” market sentiment flag add caution. The recent press release touts fast‑growing brokerage operations, but no concrete earnings improvements are evident.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price below all major SMAs
- decreasing volume and high volatility
- negative profitability and EPS
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- DCF fair value gap suggests upside potential
- strong cash position offsets earnings weakness
- revenue growth remains robust
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- significant upside to DCF fair value
- potential for margin improvement as scale increases
- low debt and ample liquidity support a turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth55.70%
Profit Margin-122.35%
ROE-14.23%
ROA-8.58%
Debt/Equity0.64
P/B Ratio0.8
Op. Cash Flow$981.4K
Industry P/E17.4
Technical Analysis
TrendBearish
RSI45.9
Support$0.75
Resistance$0.89
MA 20$0.81
MA 50$0.87
MA 200$1.08
MACDBullish
VolumeDecreasing
Fear & Greed Index90.59
Valuation
Fair Value$1.09
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.94
Volatility135.66%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.